Future epidemiological and economic impacts of universal influenza vaccines [Population Biology]

The efficacy of influenza vaccines, currently at 44%, is limited by the rapid antigenic evolution of the virus and a manufacturing process that can lead to vaccine mismatch. The National Institute of Allergy and Infectious Diseases (NIAID) recently identified the development of a universal influenza vaccine with an efficacy of...

Source: Proceedings of the National Academy of Sciences - October 7, 2019 Category: Science Authors: Pratha Sah, Jorge A. Alfaro-Murillo, Meagan C. Fitzpatrick, Kathleen M. Neuzil, Lauren A. Meyers, Burton H. Singer, Alison P. Galvani Tags: Biological Sciences Source Type: research